Management of L-Dopa Overdose in the Competitive Inhibition State [Retraction]

• Published in: Drug, healthcare and patient safety Vol. 12; pp. 271 - 272
• Main Authors: Hinz, Marty, Stein, Alvin, Cole, Ted
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 31.12.2020; Taylor & Francis Ltd; Dove; Dove Medical Press
• Subjects: dihydroxyphenylalanine; l-dopa; levodopa; parkinsons disease; Periodical publishing; Retraction
• ISSN: 1179-1365; 1179-1365
• DOI: 10.2147/DHPS.S296332

Hinz M, Stein A, Cole T. Drug Healthc Patient Saf. 2014;6:93- 99. The Editor-in-chief and Publisher of Drug, Healthcare andPatient Safety wish to retract the published article. Following the conclusion of our investigation the decisionhas been made to retract the published article. The authorsdid not provide the requested IRB and informed consentinformation relating to this study and it was determined thestudy did not meet the ethical publication requirements forresearch involving human subjects. These requirements arebased on guidelines issued by the World Medical Associationand the International Committee of Medical Journal Editors.Additionally, the authors did not provide the study protocols,raw data and other study documents relating to this study asrequested. Given our concerns about the standard of researchethics, competing interests and that the authors have notsupplied the information we requested to verify and validatethe reported findings, the editor has determined the articleshould be retracted. Our decision-making was informed by our policy on publishingethics and integrity and the COPE guidelines onretraction. The retracted article will remain online to maintain thescholarly record, but it will be digitally watermarked oneach page as "Retracted". This retraction relates to this paper